Journal of Plant Physiology & PathologyISSN: 2329-955X

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial, J Plant Physiol Pathol Vol: 13 Issue: 3

CRISPR-Cas9 in Plant Disease Resistance: Revolutionizing Crop Protection

Dr. Anika Sharma*

Department of Plant Biotechnology, Greenfield University, India

*Corresponding Author:
Dr. Anika Sharma
Department of Plant Biotechnology, Greenfield University, India
E-mail: anika.sharma@gfu.edu.in

Received: 01-May-2025, Manuscript No. jppp-26-183722; Editor assigned: 4-May-2025, Pre-QC No. jppp-26-183722 (PQ); Reviewed: 17-May-2025, QC No. jppp-26-183722; Revised: 24-May-2025, Manuscript No. jppp-26- 183722 (R); Published: 31-May-2025, DOI: 10.4172/2329-955X.1000392

Citation: Anika S (2025) CRISPR-Cas9 in Plant Disease Resistance: Revolutionizing Crop Protection. J Plant Physiol Pathol 13: 392

Introduction

Plant diseases caused by bacteria, fungi, viruses, and other pathogens pose a significant threat to global agriculture, leading to reduced crop yields, economic losses, and food insecurity. Traditional breeding methods and chemical treatments have been used to develop disease-resistant crops, but these approaches are often time-consuming, costly, and limited in precision. The advent of CRISPR-Cas9 genome editing has provided a groundbreaking tool for enhancing plant disease resistance. By enabling precise and targeted modifications of plant genomes, CRISPR-Cas9 allows scientists to improve crop resilience efficiently while minimizing unintended genetic changes [1,2].

Discussion

CRISPR-Cas9 functions as a molecular “scissors” guided by RNA molecules to recognize and edit specific DNA sequences. In plants, this technology can be applied to knock out susceptibility genes, activate resistance genes, or introduce novel genetic traits that confer immunity against pathogens. For example, editing genes involved in pathogen recognition pathways can enhance the plant’s ability to detect and respond to infections, effectively reducing disease severity [3,4].

One major advantage of CRISPR-Cas9 over conventional breeding is precision. Unlike traditional methods that involve multiple generations of crossing and selection, CRISPR-Cas9 enables direct modification of target genes in a single generation. This significantly accelerates the development of disease-resistant crops, which is particularly critical for rapidly evolving pathogens. Moreover, CRISPR-based modifications can be designed to avoid introducing foreign DNA, producing non-transgenic crops that may face fewer regulatory hurdles [5].

CRISPR-Cas9 has been successfully applied in various crops, including rice, wheat, tomatoes, and potatoes, to confer resistance against bacterial blight, fungal infections, and viral diseases. In addition, multiplexed genome editing allows simultaneous targeting of multiple genes, enhancing broad-spectrum resistance and reducing the likelihood of pathogen adaptation.

Despite its potential, challenges remain in implementing CRISPR-Cas9 for plant disease resistance. Off-target effects, efficiency of delivery methods, and variable responses among different plant species require careful optimization. Regulatory and ethical considerations also influence the adoption of genome-edited crops in different regions. Nevertheless, ongoing research continues to refine delivery systems, improve specificity, and expand the range of editable traits.

Conclusion

CRISPR-Cas9 has revolutionized plant disease resistance by providing a precise, efficient, and versatile tool for crop improvement. By enabling targeted modifications to enhance immunity against pathogens, this technology offers the potential to increase agricultural productivity, reduce reliance on chemical pesticides, and promote food security. As research progresses and regulatory frameworks evolve, CRISPR-Cas9 is poised to become a cornerstone of sustainable and resilient crop protection strategies worldwide.

References

  1. Ngwogu K, Mba I, Ngwogu A (2012) Glycaemic control amongst diabetic mellitus patients in Umuahia Metroppolis, Abia State, Nigeria. IJBAOR 1: 98-104.

    Indexed at, Google Scholar

  2. Emeka PM, Al Mukalaf A, Al Helal H, Khan TM, Almukalf MA (2017) Prevalence of poor glycemic and blood pressure control and pattern of drug use among primary health-care outpatients in Al Ahsa Saudi Arabia. Int J Health Sci 11: 38.

    Indexed at, Google Scholar

  3. Bonsembiante L, Targher G, Maffeis C (2021) Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices? Nutrients 13: 3344.

    Indexed at, Google Scholar, Crossref

  4. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142.

    Indexed at, Google Scholar, Crossref

  5. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-6.

    Indexed at, Google Scholar, Crossref

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination